An interventional study of Cold Needle Technique and Standard Intramuscular Injection in Injection Site Pain, sponsored by Bezmialem Vakif University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Bezmialem Vakif University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Pain by Bezmialem Vakif University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Bezmialem Vakif University.
Among the 10 studies in Pain by Bezmialem Vakif University, this one is one of 3 that started in 2025, is one of 9 with no phase, and was the 10th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →3 of the 10 studies in Pain by Bezmialem Vakif University are open now, in 1 country. Recruiting first, the newest first:
Bezmialem Vakif University · Sites in Turkey
Ages 18–65 · Healthy volunteers
Bezmialem Vakif University · Sites in Turkey
Ages 18–45
Bezmialem Vakif University · Sites in Turkey
Ages 16–55 · Healthy volunteers
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 78 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 60 across the 9 interventional studies, 49 across the 1 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Bezmialem Vakif University is the lead sponsor of 359 studies on the registry; 61 are open to participants now.
1 of the studies in Pain by Bezmialem Vakif University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07062757Bezmialem Vakif UniversityLymphatic Drainage Massage and Melatonin in Post-Orthognathic Surgery Pain and Edema | 2027-03-30 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Pain by Bezmialem Vakif University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial aims to evaluate the effect of the cold needle technique on pain and patient satisfaction during intramuscular injections administered to the ventrogluteal site.
The study was conducted in the internal medicine clinics of Prof. Dr. Cemil Taşçıoğlu City Hospital in Istanbul, Türkiye. A total of 78 adult patients receiving intramuscular vitamin B12 injections as part of their prescribed treatment participated in the study.
Participants were randomly assigned to an intervention group (n=40) or a control group (n=38). The intervention group received intramuscular injections using a cooled needle, while the control group received injections using the standard technique. Only the injection needle was cooled; the medication was not cooled.
Pain intensity and patient satisfaction were assessed after the injection using Visual Analog Scales (VAS).
The study aims to determine whether the cold needle technique reduces injection-related pain and improves patient satisfaction compared with the standard intramuscular injection technique.
This study was designed as a randomized controlled trial to investigate the effects of the cold needle technique on pain intensity and patient satisfaction during intramuscular injections administered to the ventrogluteal site.
The study included 78 adult patients who were receiving intramuscular vitamin B12 (cyanocobalamin) injections as part of their prescribed treatment in the internal medicine clinics of Prof. Dr. Cemil Taşçıoğlu City Hospital in Istanbul, Türkiye.
Participants were randomly allocated to two groups: an intervention group consisting of 40 patients and a control group consisting of 38 patients.
In the intervention group, sterile injection needles were cooled in an insulated container containing ice packs. The temperature was monitored using a thermometer. Immediately before the injection, the cooled needle was removed from its sterile packaging and attached to the syringe under aseptic conditions. Only the needle was cooled; the medication and syringe were not refrigerated.
In the control group, intramuscular injections were administered using the standard technique without cooling the needle.
All injections were administered to the ventrogluteal site by the same researcher. The injection procedure was otherwise identical in both groups.
Following the injection, participants assessed their pain intensity and satisfaction using Visual Analog Scales (VAS), with scores ranging from 0 to 10.
The primary outcome was injection-related pain intensity, and the secondary outcome was patient satisfaction.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this group (n=40) received intramuscular vitamin B12 injections into the ventrogluteal site using a cooled injection needle. Only the needle was cooled; the medication and syringe were not cooled.
Procedure: Cold Needle Technique
Participants in this group (n=38) received intramuscular vitamin B12 injections into the ventrogluteal site using the standard injection technique without cooling the needle.
Procedure: Standard Intramuscular Injection
Sterile injection needles were cooled in an insulated container containing ice packs. Needle temperature was monitored using a thermometer. Immediately before administration, the cooled needle was attached to the syringe under aseptic conditions. Only the needle was cooled; the vitamin B12 medication and syringe were not cooled. The injection was administered into the ventrogluteal site.
Participants received intramuscular vitamin B12 injections into the ventrogluteal site using a standard, non-cooled sterile injection needle. The injection procedure was otherwise identical to that used in the intervention group.
Pain Intensity Following Intramuscular Injection
Pain intensity was assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Time frame: Immediately after the intramuscular injection
Patient Satisfaction Following Intramuscular Injection
Patient satisfaction was assessed using a Visual Analog Scale (VAS) ranging from 0 to 10, where 0 indicates complete dissatisfaction and 10 indicates complete satisfaction. Higher scores indicate greater patient satisfaction.
Time frame: Immediately after the intramuscular injection
Plan to share: Undecided — A decision regarding the sharing of de-identified individual participant data has not yet been made. Any future data sharing will be considered in accordance with institutional policies, ethical approval, and participant confidentiality requirements.
No publications or documents are linked to this record.
Ran from Jul 2025 to primary completion in Jul 2026, 11 months.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 11 months is close to that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.